Highlands Oncology Group ( Site 5405) is a clinical research site located in Springdale, Arkansas, United States 72762.
Crixeo Health Trust Score: 58/100 (POOR). This profile has not yet been claimed by the site owner.
Highlands Oncology Group ( Site 5405) has participated in 1 clinical trials with 1 currently active.
Therapeutic areas: Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Chronic Lymphocytic, Small-Cell Lymphoma.
Sponsors: Merck Sharp & Dohme LLC.
Trust Score: 58/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Highlands Oncology Group ( Site 5405) has a Crixeo Trust Score of 58/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Highlands Oncology Group ( Site 5405) has 1 clinical trials on record, with 1 currently active. Their work covers Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Chronic Lymphocytic, Small-Cell Lymphoma.
Highlands Oncology Group ( Site 5405) has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.